Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy-Reference-Cited by-同舟云学术

Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy

Published:2014-12-10 Issue:1 Volume:235 Page:113-124
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Pavlova Elena V¹,Archer Joy²,Z Wang Susan¹,Dekker Nick³,Aerts Johannes MFG³,Karlsson Stefan⁴,Cox Timothy M¹

Affiliation:

1. Department of Medicine; University of Cambridge; Cambridge UK

2. Department of Veterinary Medicine; University of Cambridge; Cambridge UK

3. Academic Medical Centre; Amsterdam The Netherlands

4. Lund Stem Cell Centre; Lund University Hospital; Sweden

Funder

European Union, 7th Framework Programme â€˜Euclydâ€”a European Consortium for Lysosomal Storage Diseasesâ€™, Health F2/2008

The Cambridge Comprehensive Biomedical Research Centre of the National Institute of Health Research

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4452/fullpdf

Reference60 articles.

1. Ries LAG Harkins D Krapcho M et al. SEER Cancer Statistics Review 1975-2003 National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/1975_2003/

2. Increased incidence of cancer in adult Gaucher disease in western Europe;Fost;Blood Cells Mol Dis,2006

3. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients;Taddei;Am J Hematol,2009

4. Gaucher disease and cancer incidence: a study from the Gaucher Registry;Rosenbloom;Blood,2005

5. Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher's disease;Benjamin;Scand J Haematol,1979

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-Pathogenesis of Myeloma;Hematology/Oncology Clinics of North America;2024-01

2. Animal Models for the Study of Gaucher Disease;International Journal of Molecular Sciences;2023-11-07

3. Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma;Frontiers in Immunology;2023-10-31

4. Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat;Internal Medicine;2023-10-15

5. Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance;European Journal of Haematology;2023-09-25